Advanced Catalysts for Biomass Transformation

Working closely with researchers at the Centrale Lille Institute in Lille, France - Asynt has developed and supplied two custom high-pressure reactors to assist them in their development of new advanced catalysts for biomass transformation.

Asynt high pressure reactor 'in use' at the Central Lille Institute Labs


The Catalysis and Solid State Chemistry Unit in Lille brings together a large group of experienced researchers, technical and administrative support staff, plus doctoral students and post-doctoral researchers. The unit's scientific activities are divided into three fields: heterogeneous catalysis, catalysis and molecular chemistry, and solid chemistry. Within the VAALBIO group, the CatBioInnov team (led by Dr Robert Wojcieszak) is focused on the advanced catalytic upgrading of biomass materials for biorefineries, alongside research into streamlining the use of fossil resources.

Dr Robert Wojcieszak said "Our new CatBioInnov project aims to develop catalytic processes for the conversion of C1 to C6 lignocellulosic molecules, isolated from biomass, to chemical intermediates for bio-polymer and energy-driven applications such as the production of biofuels and additives for biofuels. To support this R&D we decided to invest in two high pressure reactors. The team chose to source these units from Asynt because they offer real flexibility in their high-pressure reactor production to meet individual customer needs in terms of reactor size, construction materials, pressure ratings plus a huge range of options for agitation, heating and sampling. This flexibility was a perfect solution for us! Usually, we only have milligrams of catalysts so we chose a relatively small overall volume for our high-pressure reactors. This allows us to work with a large range of different catalyst metal/substrate ratios. The possibility to work at high pressures (up to 200 Barr) was also very important for us. As our catalytic reactions are often undertaken in corrosive media the choice of the Hastelloy for the reactor construction was logical”.

Dr Wojcieszak concluded "The two 50ml Hastelloy C276 high pressure reactors supplied by Asynt enable a considerable shortening of the trial-and-error phase necessary to design our new catalyst formulations. Using these reactors, we can perform several tests per day and study the kinetics of the reactions. The Asynt high pressure reactors are also very easy to use, further reducing the time needed to perform two sequential reactions. The support from Asynt has been just perfect. They helped us with the custom design issues and answered all our queries".

For further information on the pressure reactors solutions please visit https://www.asynt.com/products/pressure-reactors/ or contact Asynt on +44-1638-781709 / [email protected].  

 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Asynt. (2023, March 24). Advanced Catalysts for Biomass Transformation. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20210408/Advanced-Catalysts-for-Biomass-Transformation.aspx.

  • MLA

    Asynt. "Advanced Catalysts for Biomass Transformation". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20210408/Advanced-Catalysts-for-Biomass-Transformation.aspx>.

  • Chicago

    Asynt. "Advanced Catalysts for Biomass Transformation". News-Medical. https://www.news-medical.net/news/20210408/Advanced-Catalysts-for-Biomass-Transformation.aspx. (accessed December 22, 2024).

  • Harvard

    Asynt. 2023. Advanced Catalysts for Biomass Transformation. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20210408/Advanced-Catalysts-for-Biomass-Transformation.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Asynt Inc. expands global presence with new USA office in San Francisco Bay Area